Literature DB >> 7718849

Dysregulation of homeostasis of blood T-lymphocyte subpopulations persists in chronic multibacillary pulmonary tuberculosis patients refractory to treatment.

M Bose1, A Gupta, J N Banavalikar, K Saha.   

Abstract

DESIGN: The dysregulation of homeostasis of blood-T lymphocyte subpopulations was studied in 21 cases of chronic, multibacillary pulmonary tuberculosis refractory to treatment. The clinico-bacteriological and immunological parameters studied in these cases (Gr A) were compared with those of a group of 10 newly-diagnosed drug sensitive cases of pulmonary tuberculosis (Gr B) at the beginning of the study and after 3 months of chemotherapy for tuberculosis. The chronic cases were treated with drugs selected from a reserve line. 10 normal healthy individuals were included in this study as a control group.
RESULTS: At the beginning of the study the mean CD4/CD8 lymphocyte ratios in the refractory cases (0.69) and the newly diagnosed cases (0.81) were significantly lower than those of the normal control subjects (1.84). After 3 months of chemotherapy all but 3 of the newly-diagnosed cases showed clinical improvement, and all became sputum-negative. Their CD4/CD8 ratio recorded a rise to near normal (1.54). On the contrary, following 3 months of reserve-line regimen, only 7 of the 21 group A cases showed sputum conversion. In all of the refractory cases, irrespective of sputum conversion, the CD4/CD8 ratio remained low (1.05).
CONCLUSION: This probably indicates that due to a long-standing bacillary load in drug resistant pulmonary tuberculosis patients the dysregulation of homeostasis of blood-T lymphocytes becomes persistent. This in turn delays their clinical and immunological recovery, even when therapy is adequate.

Entities:  

Mesh:

Year:  1995        PMID: 7718849     DOI: 10.1016/0962-8479(95)90581-2

Source DB:  PubMed          Journal:  Tuber Lung Dis        ISSN: 0962-8479


  6 in total

1.  Dichotomy of cytokine profiles in patients and high-risk healthy subjects exposed to tuberculosis.

Authors:  S Bhattacharyya; R Singla; A B Dey; H K Prasad
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

2.  Sensitivity and specificity of the mean corpuscular volume and CD4/CD8 ratio in discriminating between rifampicin resistant and rifampicin sensitive tuberculosis.

Authors:  Joseph Baruch Baluku; Joseph Musaazi; Rose Mulwana; Derrick Bengo; Christine Sekaggya Wiltshire; Irene Andia-Biraro
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2020-11-23

3.  Prospective study of immunomodulation in osteoarticular tuberculosis non responsive to anti tubercular therapy.

Authors:  B P Sharma; Amit Kumar; Saubhik Das; Shambhu Prasad
Journal:  J Clin Orthop Trauma       Date:  2017-07-03

4.  CD4+ T-lymphopenia in HIV negative tuberculous patients at King Khalid University Hospital in Riyadh, Saudi Arabia.

Authors:  Abdulkarim Al-Aska; A R Al-Anazi; S S Al-Subaei; M A Al-Hedaithy; M A Barry; A M Somily; F Buba; U Yusuf; N A Al Anazi
Journal:  Eur J Med Res       Date:  2011-06-21       Impact factor: 2.175

Review 5.  The CD4+/CD8+ Ratio in Pulmonary Tuberculosis: Systematic and Meta-Analysis Article.

Authors:  Yongmei Yin; Jie Qin; Yaping Dai; Fanwei Zeng; Hao Pei; Jun Wang
Journal:  Iran J Public Health       Date:  2015-02       Impact factor: 1.429

6.  Association of Immune Factors with Drug-Resistant Tuberculosis: A Case-Control Study.

Authors:  En-Tao Sun; Dan Xia; Ben-He Li; Jun Ma; Yuan-Yuan Dong; Shu-Shu Ding; Bai-Feng Chen; Yu-Feng Wen
Journal:  Med Sci Monit       Date:  2017-11-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.